HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

被引:0
|
作者
Yvonne N. Flores
David M. Bishai
Attila Lőrincz
Keerti V. Shah
Eduardo Lazcano-Ponce
Mauricio Hernández
Víctor Granados-García
Ruth Pérez
Jorge Salmerón
机构
[1] Instituto Mexicano del Seguro Social,Unidad de Investigación Epidemiológica y en Servicios de Salud
[2] Johns Hopkins University,Department of Population, Family, and Reproductive Health
[3] Bloomberg School of Public Health,Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine
[4] Queen Mary University of London,Department of Molecular Microbiology and Immunology
[5] Johns Hopkins University,Centro de Investigación en Salud Poblacional
[6] Bloomberg School of Public Health,Secretaria de Prevención y Promoción de la Salud
[7] Instituto Nacional de Salud Pública,Unidad de Investigación en Economía de la Salud
[8] Secretaría de Salud,Departamento de Abastecimiento, Instituto Mexicano del Seguro Social
[9] Instituto Mexicano del Seguro Social,undefined
[10] Hospital General Regional No. 1,undefined
来源
Cancer Causes & Control | 2011年 / 22卷
关键词
Cost-effectiveness; Cervical cancer; HPV; Screening; Mexico;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:261 / 272
页数:11
相关论文
共 50 条
  • [1] HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
    Flores, Yvonne N.
    Bishai, David M.
    Lorincz, Attila
    Shah, Keerti V.
    Lazcano-Ponce, Eduardo
    Hernandez, Mauricio
    Granados-Garcia, Victor
    Perez, Ruth
    Salmeron, Jorge
    CANCER CAUSES & CONTROL, 2011, 22 (02) : 261 - 272
  • [2] Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Oishi, Tetsuro
    Kigawa, Junzo
    Iwanari, Osamu
    Kasai, Tokuzo
    Kurokawa, Tetsuji
    Hamada, Masao
    Fujita, Hiromasa
    Fujiwara, Hiroyuki
    Yokoyama, Masatoshi
    Sakuragi, Noriaki
    Harada, Tasuku
    Suzuki, Mitsuaki
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 158 (01) : 187 - 193
  • [3] HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
    Richardson, Lyndsay Ann
    El-Zein, Mariam
    Ramanakumar, Agnihotram V.
    Ratnam, Samuel
    Sangwa-Lugoma, Ghislain
    Longatto-Filho, Adhemar
    Cardoso, Marly Augusto
    Coutlee, Francois
    Franco, Eduardo L.
    CANCER CYTOPATHOLOGY, 2015, 123 (12) : 745 - 754
  • [4] Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
    El-Zein, Mariam
    Richardson, Lyndsay
    Franco, Eduardo L.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 76 : S62 - S68
  • [6] Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico:: The Morelos HPV Study
    Flores, Y
    Shah, K
    Lazcano, E
    Hernández, M
    Bishai, D
    Ferris, DG
    Lörincz, A
    Hernández, P
    Salmerón, J
    SALUD PUBLICA DE MEXICO, 2002, 44 (04): : 335 - 344
  • [7] HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
    Caeiro, Vitor
    Esteves, Bruno
    Fonseca-Moutinho, Jose
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [8] HPV vaccination in China needs to be more cost-effective
    Yin, Yue
    LANCET, 2017, 390 (10104): : 1735 - 1736
  • [9] Breast cancer screening; cost-effective in practice?
    de Koning, HJ
    EUROPEAN JOURNAL OF RADIOLOGY, 2000, 33 (01) : 32 - 37
  • [10] HPV Testing and its Role in Cervical Cancer Screening
    Clarke, Megan A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2023, 66 (03): : 448 - 469